The global stem cell therapy market is expected to witness a CAGR of 10.6% during the forecast period 2019-2024 and is also anticipated to reach USD 214.5 million by 2024. Growing awareness related to the therapeutic potency of stem cells, development of infrastructure related to stem cell banking and processing, development of advanced genome-based cell analysis techniques, and increasing private-public investment for the development of stem cell therapies are driving the growth of the stem cell therapy market.

Download Free Report Sample At: https://www.vynzresearch.com/healthcare/stem-cell-therapy-market/request-sample

The North American stem cell therapy market will remain the largest during the forecast period. The region is further predicted to observe the fastest growth during the forecast period in the global market owing to technological upgradation and large capital invested in the research and development activities. Moreover, increasing number of clinical trials to evaluate therapeutic potential of products, increasing prevalence of chronic diseases, the growing patient base for target diseases, growing public awareness related to the therapeutic potency of therapy, and increasing public-private funding & research grants for developing safe and effective stem cell therapy products are also supporting the growth of the North American stem cell therapy market.

Major players in the industry are investing in the development of innovative and new products, which is strengthening their position in the stem cell therapy market. In February 2018, MEDIPOST announced that FDA has approved its stem cell-based Alzheimer’s disease drug, NEUROSTEM for clinical trials. Similarly, in March 2017, Osiris Therapeutics launched Prestige Lyotechnology, a method for storage of living cells and tissues.

Read More: https://www.vynzresearch.com/healthcare/stem-cell-therapy-market

Some of the key players operating in the stem cell therapy industry are Osiris Therapeutics, Inc., RTI Surgical, Inc., MEDIPOST Co., Ltd., Nuvasive, Inc., Pharmicell Co., Ltd., Holostem Terapie Avanzate Srl, JCR Pharmaceuticals Co., Ltd., Anterogen Co., Ltd., and Allosource.

Global Stem Cell Therapy Market Coverage

Type Insight and Forecast 2014-2024

Allogeneic
Autologous
Cell Source Insight and Forecast 2014-2024

Adipose Tissue-Derived Mesenchymal Stem Cell
Cord Blood Cells
Bone Marrow-Derived Mesenchymal Stem Cells

Therapeutic Application Insight and Forecast 2014-2024

Gastrointestinal Diseases
Musculoskeletal Disorders
Surgeries
Cardiovascular Diseases
Wound & Injuries

Geographic Segmentation

Stem Cell Therapy Market by Region

North America
U.S.
Canada
Europe
Germany
U.K.
France
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
ROW
Brazil
Other Countries

About VynZ Research
VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

Contact

Manager: Client Care

Toll-Free: 18882533960

Email: [email protected]

Website: www.vynzresearch.com